RT @cancer_ref: 「骨転移を伴う前立腺がん患者に対する骨修飾薬」がコクランレビューに掲載されました。 https://t.co/BBWHQrb2Tx https://t.co/EDTKTb8Vp3 #骨転移 #前立腺がん https://t.co/Jaulpon…
「骨転移を伴う前立腺がん患者に対する骨修飾薬」がコクランレビューに掲載されました。 https://t.co/BBWHQrb2Tx https://t.co/EDTKTb8Vp3 #骨転移 #前立腺がん https://t.co/JaulponqjP
RT @CochraneJapan: 骨転移を伴う前立腺がん患者に対する骨修飾薬 https://t.co/VTkFyzPuoL
骨転移を伴う前立腺がん患者に対する骨修飾薬 https://t.co/VTkFyzPuoL
Academic correctness within some Cochrane Reviews – a double-edge sword – more rigour, but rather bland too...? https://t.co/q4b7BUixJx https://t.co/rUj5J2ao4u
Explore evidence from 25 trials in this @CochraneLibrary network meta-analysis on bone‐modifying agents for men with #ProstateCancer and bone metastases: https://t.co/4QkiE3quj4 https://t.co/pL1AaZroLp
RT @CochraneLibrary: Bone‐modifying agents for men with #prostatecancer and bone metastases https://t.co/YvimXsykAN This network meta‐analy…
Bone‐modifying agents for men with #prostatecancer and bone metastases https://t.co/YvimXsykAN This network meta‐analysis from @CochraneUrology includes evidence from 25 trials.
RT @CochraneUK: Bone‐modifying agents for men with #prostatecancer and bone metastases https://t.co/ZMltJou5Xy This network meta‐analysis f…
Bone‐modifying agents for men with #prostatecancer and bone metastases https://t.co/ZMltJou5Xy This network meta‐analysis from @CochraneUrology includes evidence from 25 trials. https://t.co/lmrp2Yk2kw
【コクランレビュー】前立腺癌および骨転移のある男性に対するビスホスホネートやRANKL阻害薬(ゾレドロン酸の使用は、未治療/プラセボと比較して疼痛反応の割合を減少も増加もさせないかもしれず、腎機能障害はより多く発生するかもしれない。) #ペ読 https://t.co/D2bWliGd64
New article: Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis. https://t.co/suFH0f6SBo #prostatecancer #oncology https://t.co/xBRr8TpwLT
RT @CancerWallonia: #Bisphosphonates or #RANK-#ligand-#inhibitors for men with #prostate #cancer and #bone #metastases: a network meta-#ana…
#Bisphosphonates or #RANK-#ligand-#inhibitors for men with #prostate #cancer and #bone #metastases: a network meta-#analysis (followed by Marc #Lacroix, #Wallonia) https://t.co/sZUEFDTGDF #oncology